TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Novus Scientific AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
28,709
|
23,090
|
14,546 |
| Financial expenses |
2,931
|
118
|
57 |
| Earnings before taxes |
2,429
|
5,212
|
-3,969 |
| EBITDA |
9,398
|
4,673
|
-4,294 |
| Total assets |
30,943
|
30,626
|
25,316 |
| Current assets |
29,400
|
28,976
|
23,198 |
| Current liabilities |
22,416
|
22,429
|
22,346 |
| Equity capital |
8,527
|
8,197
|
2,970 |
| - share capital |
65
|
67
|
67 |
| Employees (average) |
16
|
16
|
16 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
27.6%
|
26.8%
|
11.7% |
| Turnover per employee |
1,794
|
1,443
|
909 |
| Profit as a percentage of turnover |
8.5%
|
22.6%
|
-27.3% |
| Return on assets (ROA) |
17.3%
|
17.4%
|
-15.5% |
| Current ratio |
131.2%
|
129.2%
|
103.8% |
| Return on equity (ROE) |
28.5%
|
63.6%
|
-133.6% |
| Change turnover |
6,383
|
8,469
|
2,581 |
| Change turnover % |
29%
|
58%
|
22% |
| Chg. No. of employees |
0
|
0
|
2 |
| Chg. No. of employees % |
0%
|
0%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.